3497 related articles for article (PubMed ID: 27638987)
41. Delayed child-bearing.
Johnson JA; Tough S;
J Obstet Gynaecol Can; 2012 Jan; 34(1):80-93. PubMed ID: 22260768
[TBL] [Abstract][Full Text] [Related]
42. Guidelines for the management of vasa previa.
Gagnon R; ;
J Obstet Gynaecol Can; 2009 Aug; 31(8):748-753. PubMed ID: 19772710
[TBL] [Abstract][Full Text] [Related]
43. Guideline No. 450: Care of Pregnant Women Living with HIV and Interventions to Reduce Perinatal Transmission.
Atkinson A; Tulloch K; Boucoiran I; Money D
J Obstet Gynaecol Can; 2024 Jun; 46(6):102551. PubMed ID: 38734074
[TBL] [Abstract][Full Text] [Related]
44. Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral Infections.
Wilson RD
J Obstet Gynaecol Can; 2020 Dec; 42(12):1555-1562.e1. PubMed ID: 33308791
[TBL] [Abstract][Full Text] [Related]
45. Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects.
Douglas Wilson R; Van Mieghem T; Langlois S; Church P
J Obstet Gynaecol Can; 2021 Jan; 43(1):124-139.e8. PubMed ID: 33212246
[TBL] [Abstract][Full Text] [Related]
46. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Henneman L; Kai J; Qureshi N
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010849. PubMed ID: 34634131
[TBL] [Abstract][Full Text] [Related]
47. Choosing Pre-conception Planning for Women/Families: Counselling and Informed Consent (Part 2) - Pre-conception Reproductive Planning, Lifestyle, Immunization, and Psychosocial Issues.
Wilson RD
J Obstet Gynaecol Can; 2019 May; 41(5):666-678. PubMed ID: 29223750
[TBL] [Abstract][Full Text] [Related]
48. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women.
Singh S; Best C; Dunn S; Leyland N; Wolfman WL
J Obstet Gynaecol Can; 2018 May; 40(5):e391-e415. PubMed ID: 29731212
[TBL] [Abstract][Full Text] [Related]
49. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
[TBL] [Abstract][Full Text] [Related]
50. Antibiotic therapy in preterm premature rupture of the membranes.
Yudin MH; van Schalkwyk J; Eyk NV; ;
J Obstet Gynaecol Can; 2009 Sep; 31(9):863-867. PubMed ID: 19941711
[TBL] [Abstract][Full Text] [Related]
51. Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.
Sagaser KG; Malinowski J; Westerfield L; Proffitt J; Hicks MA; Toler TL; Blakemore KJ; Stevens BK; Oakes LM
J Genet Couns; 2023 Jun; 32(3):540-557. PubMed ID: 36756860
[TBL] [Abstract][Full Text] [Related]
52. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.
Samson L; King S
CMAJ; 1998 Jun; 158(11):1449-57. PubMed ID: 9629106
[TBL] [Abstract][Full Text] [Related]
53. Elective single embryo transfer following in vitro fertilization.
Min JK; Hughes E; Young D; ;
J Obstet Gynaecol Can; 2010 Apr; 32(4):363-377. PubMed ID: 20500945
[TBL] [Abstract][Full Text] [Related]
54. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
ACOG Committee on Genetics
Obstet Gynecol; 2004 Aug; 104(2):425-8. PubMed ID: 15292027
[TBL] [Abstract][Full Text] [Related]
55. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
56. Genetic considerations for a woman's pre-conception evaluation.
Douglas Wilson R;
J Obstet Gynaecol Can; 2011 Jan; 33(1):57-64. PubMed ID: 21272438
[TBL] [Abstract][Full Text] [Related]
57. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
58. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
59. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010849. PubMed ID: 29537064
[TBL] [Abstract][Full Text] [Related]
60. Canadian HIV pregnancy planning guidelines.
Loutfy MR; Margolese S; Money DM; Gysler M; Hamilton S; Yudin MH
J Obstet Gynaecol Can; 2012 Jun; 34(6):575-590. PubMed ID: 22673174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
